Quinones can in principle be viewed as a double-edged sword in the treatment of
neurodegenerative diseases, since they are often cytoprotective but can also be cytotoxic …

Alzheimer's disease (AD) is a multifactorial, rapidly progressing neurodegenerative disorder.
As the exact cause of the disease is still unclear, the drug development is very challenging …

Alzheimer's disease (AD), a progressive neurodegenerative disease characterized by
impairments of cognitive function as a result of synaptic deficits and neuronal loss, is …

The most common form of dementia, Alzheimer's disease (AD), is characterized by gradual
declines in cognitive abilities and behavior. It is caused by a combination of factors …

Mental disorders have a poor clinical prognosis and account for approximately 8% of the
global burden of disease. Some examples of mental disorders are anxiety and depression …

Alzheimer's disease (AD) is a progressive neuronal/cognitional dysfunction, leading to
disability and death. Despite advances in revealing the pathophysiological mechanisms …

Sterubin, a flavanone is an active chemical compound that possesses neuroprotective
activity. The current investigation was intended to assess the sterubin effect in scopolamine …

Alzheimer's disease is regarded as a common neurodegenerative disease that may lead to
dementia and the loss of memory. We report here the nootropic and anti-amnesic effects of …

The complex and multifaceted nature of Alzheimer's disease has brought about a pressing
demand to develop ligands targeting multiple pathways to combat its outrageous …

Alzheimer's disease (AD) is one of the most prevalent and progressive neurodegenerative
disorders, hallmarked by increased amyloid-β deposition and enhanced oxidative load in …